Ukutya kwe-Esophageal Adenocarcinoma!

intshayelelo

Ukutya kwe-Esophageal Adenocarcinoma kufuneka ilungiselelwe umntu ngamnye kwaye kufuneka ilungelelanise xa unyango lomhlaza okanye utshintsho lwemfuzo yethumba. Ukwenziwa komntu kunye nokulungelelaniswa kufuneka kuthathelwe ingqalelo zonke izithako ezisebenzayo okanye i-bioactives equlethwe kukutya okwahlukeneyo malunga nebhayoloji yethishu yomhlaza, imfuzo, unyango, iimeko zokuphila kunye nokukhethwa kokutya. Kungoko ngexa isondlo sesinye sezigqibo ezibaluleke kakhulu kwisigulana somhlaza kunye nomntu osemngciphekweni wokuba nomhlaza – ukukhetha ukutya oza kukutya akuyondlwan’ iyanetha.

I-Esophageal adenocarcinoma luhlobo lomhlaza olwenzeka kwiiseli zommizo. Ikhowudi yonyango echanekileyo usebenzisa ikhowudi ye-ICD-10 efanelekileyo ibalulekile kumaxwebhu. Iimpawu zePathology zibonelela ngolwazi oluxabisekileyo malunga neempawu zeeseli ze-adenocarcinoma ze-esophageal. Ukwenziwa kweqonga kudlala indima ebalulekileyo ekumiseleni ubungakanani kunye nokusasazeka komhlaza kunye nezigqibo ezikhokelayo zonyango. I-prognosis ye-adenocarcinoma ye-esophageal iyahluka ngokuxhomekeke kwinqanaba lomhlaza kunye nezinye izinto. Iinketho zonyango kwi-adenocarcinoma ye-esophageal zinokubandakanya ichemotherapy, unyango lwemitha, utyando, okanye indibaniselwano yezi ndlela. Ukuqaphela izinto ezinobungozi ezinxulumene ne-adenocarcinoma ye-esophageal kubalulekile, njengoko izinto ezifana nokukhuluphala, isifo se-reflux ye-gastroesophageal (GERD), kunye nokutshaya kunokunyusa umngcipheko. Ngokufuna ukuxilongwa kwangaphambili kunye nonyango olufanelekileyo, abantu abane-adenocarcinoma ye-esophageal banokuphucula iziphumo zabo zonyango kunye ne-prognosis jikelele.

Kwi-Esophageal Adenocarcinoma ingaba ibalulekile ukuba yeyiphi imifuno, iziqhamo, amandongomane, imbewu ayityayo?

Umbuzo oxhaphake kakhulu ngezondlo obuzwa zizigulane ezinomhlaza kunye nabantu abasengozini yomhlaza ngowomhlaza onje nge-Esophageal Adenocarcinoma ingaba ibalulekile into yokuba kukutya endikutyayo okanye endingakutyiyo? Okanye ukuba ndilandela ukutya okusekwe kwisityalo ngaba kwanele umhlaza onje nge-Esophageal Adenocarcinoma?

Umzekelo ingaba inomsebenzi ukuba imifuno yaseNew Zealand isipinatshi ityiwa kakhulu xa ithelekiswa neKohlrabi? Ngaba kuyawenza umahluko xa kukhethwa isiqhamo iPummelo kuneGrapefruit/pummelo Hybrid? Kwakhona ukuba ukhetho olufanayo lwenziwa kwiindongomane/iimbewu ezifana neButternut ngaphezu kweCashew Nut kunye nezityalo ezifana neBroad Bean phezu kweLima Bean. Kwaye ukuba into endiyityayo ibalulekile - umntu uchonga njani ukutya okucetyiswayo kwi-Esophageal Adenocarcinoma kwaye ingaba yimpendulo efanayo kuye wonke umntu onoxilongo olufanayo okanye umngcipheko wemfuzo?

Ewe! Ukutya okutyayo kubalulekile kwi-Esophageal Adenocarcinoma!

Iingcebiso zokutya zisenokungafani kumntu wonke kwaye zinokwahluka nakwisifo esifanayo kunye nomngcipheko wemfuzo.

Konke ukutya (imifuno, iziqhamo, amandongomane, iimbewu, i-pulses, i-oyile njl.njl.) kunye nezongezo zesondlo zenziwe ngaphezu kwesinye isithako esisebenzayo semolekyuli okanye i-bio-actives ngokwemilinganiselo eyahlukeneyo kunye nezixa. Isithako ngasinye esisebenzayo sinendlela ekhethekileyo yokusebenza - enokuthi isebenze okanye ithintele iindlela ezahlukeneyo ze-biochemical. Ukutya okuchazwe ngokulula kunye nezongezo ezicetyiswayo zezo zingabangeli ukwanda kwabaqhubi beemolekyuli zomhlaza kodwa zibanciphise. Okanye oko kutya akufuneki kunconywe. Ukutya kuqulethe izithako ezininzi ezisebenzayo - kungoko xa uvavanya ukutya kunye nezongezelelo kufuneka uqwalasele ifuthe lazo zonke izithako ezisebenzayo ngokongezelekayo kunomntu ngamnye.

Umzekelo iPummelo iqulethe izithako ezisebenzayo i-Quercetin, i-Apigenin, i-Curcumin, i-Lycopene, i-Isoliquiritigenin. Kwaye iGrapefruit / pummelo Hybrid iqulethe izithako ezisebenzayo i-Apigenin, i-Curcumin, i-Lycopene, i-Myricetin, i-Isoliquiritigenin kwaye mhlawumbi nabanye.

Iphutha eliqhelekileyo elenziwe xa kuthathwa isigqibo kunye nokukhetha ukutya okutyayo kwi-Esophageal Adenocarcinoma - kukuvavanya kuphela izithako ezisebenzayo ezikhethiweyo eziqulethwe kukutya kwaye ungayihoyi yonke into. Ngenxa yokuba izithako ezahlukeneyo ezisebenzayo eziqulethwe kukutya zinokuba neziphumo ezichasayo kubaqhubi bomhlaza - awukwazi ukukhetha izithako ezisebenzayo ekutyeni kunye nezongezelelo zokwenza isigqibo sesondlo se-Esophageal Adenocarcinoma.

EWE – UKHETHO LOKUTYA LUYINGABA NOMHLAZA. IZIGQIBO ZOKUTYA KUFUNEKA IZIQWELELE ZONKE IZINTO EZISEBENZAYO ZOKUTYA.

Izakhono ezifunekayo kuMntu weSondlo kwi-Esophageal Adenocarcinoma?

Isondlo esilungiselelwe wena somhlaza njenge-Esophageal Adenocarcinoma siquka ukutya okucetyiswayo / izongezo; ukutya okungacetyiswanga / izongezo ezinomzekelo weeresiphi ezibeka phambili ukusetyenziswa kokutya okucetyiswayo. Umzekelo wesondlo somntu unokubonwa koku ikhonkco.

Ukugqiba ukuba kukuphi ukutya okucetyiswayo okanye okungacetyiswayo kuntsonkothile kakhulu, kufuna ubuchwephesha kwi-Esophageal Adenocarcinoma biology, isayensi yokutya, imfuzo, i-biochemistry kunye nokuqonda kakuhle ukuba unyango lomhlaza lusebenza njani kunye nokuba semngciphekweni okunxulumene nonyango olunokuthi luyeke ukusebenza.

UBUCHULE OBUBONA ULWAZI OLUFUNEKAYO UKUZE SONDLWE UMNTU WOMHLAZA ZI: IBHALOJI YOMHLAZA, ISAYENSI YOKUTYA, UNYANGO LOMHLAZA KUNYE NEMFUZO.

Iimpawu zomhlaza ezifana ne-Esophageal Adenocarcinoma

Zonke ii-cancer ezifana ne-Esophageal Adenocarcinoma zinokubonakaliswa ngoluhlu olulodwa lweendlela ze-biochemical - iindlela zokutyikitya ze-Esophageal Adenocarcinoma. Iindlela ze-Biochemical ezifana ne-Apoptosis, i-Cell Cycle, i-PI3K-AKT-MTOR Ukubonakaliswa, ukubonakaliswa kwe-MAPK kuyingxenye yenkcazo yesignesha ye-Esophageal Adenocarcinoma. Imfuzo yomhlaza yomntu ngamnye inokwahluka kwaye kungoko utyikityo lwabo lomhlaza lunokwahluka.

Unyango olusebenzayo kwi-Esophageal Adenocarcinoma kufuneka luthathele ingqalelo utyikityo olunxulumene neendlela zebhayokhemikhali kwisigulana somhlaza ngamnye kunye nomntu osengozini yemfuzo. Ngoko ke unyango oluhlukeneyo ngeendlela ezahlukeneyo zezenzo zisebenza kakuhle kwizigulane ezahlukeneyo. Ngokufanayo kwaye ngenxa yezizathu ezifanayo ukutya kunye nezongezo kufuneka zenziwe kumntu ngamnye. Yiyo loo nto okunye ukutya kunye nezongezo zicetyiswayo kwi-Esophageal Adenocarcinoma xa uthatha unyango lomhlaza i-Docetaxel, kwaye okunye ukutya kunye nezongezo azikhuthazwa.

Imithombo efana cBioPortal kunye nabanye abaninzi banikezela ngedatha emele isigulana esingaziwa kulingo lwezonyango kuzo zonke iimpawu zomhlaza. Le datha iqulathe iinkcukacha zophononongo lwezonyango ezifana nobungakanani besampulu / inani lezigulana, amaqela obudala, isini, ubuhlanga, unyango, indawo yethumba kunye naluphi na utshintsho lwemfuza.

I-TP53, i-MUC16, i-FAT3, i-LAMA1 kunye ne-FAT4 zezona ziphezulu iijene ezixeliweyo ze-Esophageal Adenocarcinoma. I-TP53 ixelwe kwi-10.4% yezigulane ezimele kuzo zonke iimvavanyo zekliniki. Kwaye i-MUC16 inikwe ingxelo nge-4.0%. Idatha ehlanganisiweyo yedatha yesigulane igubungela iminyaka yobudala ukusuka kuma-32 ukuya kuma-88. I-85.4 % yedatha yesigulane ichongwa njengamadoda. Ibhayoloji ye-Esophageal Adenocarcinoma kunye ne-genetics exeliweyo kunye zichaza inani labantu elimelwe utyikityo lweendlela zebhayoloji kulo mhlaza. Ukuba ithumba lomhlaza lomntu ngamnye lifuzo okanye imfuza enegalelo kumngcipheko nayo iyaziwa ke leyo kufuneka isetyenziselwe ukwenziwa kwesondlo.

UKHETHO LWESONDLO MELE LUHAMBANE NOMNTU NGAMNYE WOMNTU WOMNTU.

Ukutya kunye nezongezo ze-Esophageal Adenocarcinoma

Kwizigulane zoMhlaza

Izigulana zomhlaza ezikunyango okanye kukhathalelo lokuthomalalisa kufuneka zenze izigqibo ngokutya kunye nezongezelelo - kwiikhalori ezifunekayo zokutya, ukulawula naziphi na iziphumo ebezingalindelekanga zonyango kunye nokuphuculwa kolawulo lomhlaza. Konke ukutya okusekelwe kwizityalo akulingani kwaye ukukhetha kunye nokubeka phambili ukutya okwenziwa ngumntu kwaye kulungiselelwe unyango oluqhubekayo lomhlaza kubalulekile kwaye kunzima. Nantsi eminye imizekelo ebonelela ngezikhokelo zokwenza izigqibo zesondlo.

Khetha imifuno NEW ZEALAND SPINACH okanye KOHLRABI?

Imifuno yaseNew Zealand Isipinatshi iqulethe izithako ezininzi ezisebenzayo okanye i-bioactives efana ne-Quercetin, i-Apigenin, i-Curcumin, i-Lycopene, i-Myricetin. Ezi zithako ezisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-RAS-RAF Signaling, i-PI3K-AKT-MTOR Umqondiso kunye ne-Chemokine Signaling kunye nabanye. Isipinatshi saseNew Zealand sinconywa kwi-Esophageal Adenocarcinoma xa unyango lomhlaza oluqhubekayo yi-Docetaxel. Oku kungenxa yokuba isipinatshi saseNew Zealand siguqula iindlela zebhayomichiza eziye zaxelwa ngokwenzululwazi ukuze zikhuthaze isiphumo seDocetaxel.

Ezinye zezinto ezisebenzayo okanye i-bioactives kwimifuno ye-Kohlrabi yi-Quercetin, i-Curcumin, i-Isoliquiritigenin, i-Formononetin, i-Luteolin. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Heat Stress Response kunye nezinye. I-Kohlrabi ayikhuthazwa kwi-Esophageal Adenocarcinoma xa unyango lomhlaza oluqhubekayo yi-Docetaxel kuba luguqula ezo ndlela ze-biochemical eyenza ukuba unyango lomhlaza luxhathise okanye lungaphenduli.

IMIFUNO ENTSHA ZEALAND ISIPINACH IYANCEBISWA NGE-KOHLRABI YE-Esophageal Adenocarcinoma KUNYE NONYANGO Docetaxel.

Khetha iSiqhamo GRAPEFRUIT/PUMMELO HYBRID okanye iPUMMELO?

Isiqhamo seGrapefruit / pummelo Hybrid iqulethe izithako ezininzi ezisebenzayo okanye i-bioactives efana ne-Apigenin, i-Curcumin, i-Lycopene, i-Myricetin, i-Isoliquiritigenin. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Extracellular Matrix Remodelling, i-NFKB Signaling, i-Cell Cycle kunye ne-Epithelial kwi-Mesenchymal Transition kunye nabanye. IGrapefruit/pummelo Hybrid iyacetyiswa kwi-Esophageal Adenocarcinoma xa unyango lomhlaza oluqhubekayo yiDocetaxel. Oku kungenxa yokuba iGrapefruit/pummelo Hybrid ilungisa iindlela zebhayomichiza ekuye kwaxelwa ngazo ngokwenzululwazi ukuba zinike impembelelo yeDocetaxel.

Ezinye zezinto ezisebenzayo okanye i-bioactives kwiziqhamo iPummelo yi-Quercetin, i-Apigenin, i-Curcumin, i-Lycopene, i-Isoliquiritigenin. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-WNT Beta Catenin Signaling, i-Microtubule Dynamics kunye ne-Heat Stress Response kunye nezinye. IPummelo ayikhuthazwa kwi-Esophageal Adenocarcinoma xa unyango lomhlaza oluqhubekayo yi-Docetaxel kuba luguqula ezo ndlela ze-biochemical ezenza ukuba unyango lomhlaza luxhathise okanye lungaphenduli.

ISIQHAMO SOMGRAPEFRUIT/IPUMMELO HYBRID IYAKUNIKEZISWA NGAPHEZU KWE-PUMMELO YE-Esophageal Adenocarcinoma KUNYE NONYANGO I-Docetaxel.

Khetha i-Nutt BUTTERNUT okanye i-CASHEW NUT?

I-Butternut iqulethe izithako ezininzi ezisebenzayo okanye i-bioactives efana ne-Apigenin, i-Curcumin, i-Lycopene, i-Myricetin, i-Isoliquiritigenin. Ezi zithako ezisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Extracellular Matrix Remodelling, i-NFKB Signaling, i-PI3K-AKT-MTOR yokuSayina kunye ne-RAS-RAF yokuSayina kunye nabanye. I-Butternut iyacetyiswa kwi-Esophageal Adenocarcinoma xa unyango lomhlaza oluqhubekayo yi-Docetaxel. Oku kungenxa yokuba i-Butternut ilungisa ezo ndlela zebhayoloji ezixelwe ngokwenzululwazi ukwazisa isiphumo se-Docetaxel.

Ezinye zezinto ezisebenzayo okanye i-bioactives kwi-Cashew Nut yi-Quercetin, i-Curcumin, i-Myricetin, i-Isoliquiritigenin, i-Formononetin. Ezi zithako ezisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-NFKB Signaling, i-PI3K-AKT-MTOR Umqondiso kunye nokuPhendula koxinzelelo lobushushu kunye nabanye. I-Cashew Nut ayikhuthazwa kwi-Adenocarcinoma ye-Esophageal xa unyango lomhlaza oluqhubekayo yi-Docetaxel kuba luguqula ezo ndlela ze-biochemical eyenza ukuba unyango lomhlaza luxhathise okanye lungaphenduli.

IBHUTTERNUT IYAYINGCEBISWA NGAPHEZU KWE-CASHEW NUT YE-Esophageal Adenocarcinoma KUNYE NONYANGO I-Docetaxel.

Kubantu ngabanye abaneMngcipheko yeGenetic yoMhlaza

Umbuzo obuzwayo ngabantu abasengozini yemfuza ye-Esophageal Adenocarcinoma okanye imbali yosapho ithi "Yintoni endifanele nditye ngokwahlukileyo kunangaphambili?" kunye nendlela ekufuneka bakhethe ngayo ukutya kunye nezongezo zokulawula imingcipheko yesi sifo. Kuba kumngcipheko womhlaza akukho nto inokwenzeka malunga nonyango - izigqibo zokutya kunye nezongezo zibalulekile kwaye yenye yezinto ezimbalwa ezinokuthi zenziwe. Konke ukutya okusekelwe kwizityalo akulingani kwaye kusekelwe kwi-genetics echongiweyo kunye nendlela yokutyikitya - ukhetho lokutya kunye nezongezelelo kufuneka lube lolwakho.

Khetha iVegetable GIANT BUTTERBUR or GARLAND CHRYSANTHEMUM?

I-Butterbur enkulu yemifuno iqulethe izithako ezininzi ezisebenzayo okanye i-bioactives efana ne-Apigenin, i-Curcumin, i-Lupeol, i-Daidzein, i-Phloretin. Ezi zithako ezisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Cell Cycle, i-Epithelial ukuya kwi-Mesenchymal Transition, i-Growth Factor Signaling kunye ne-P53 Signaling kunye nabanye. I-Giant Butterbur iyacetyiswa kumngcipheko we-Esophageal Adenocarcinoma xa ingozi yemfuzo ehambelana nayo yi-FAT3. Oku kungenxa yokuba i-Giant Butterbur yonyusa ezo ndlela zebhayoloji ezichasene nabaqhubi bayo.

Ezinye zezinto ezisebenzayo okanye i-bioactives kwimifuno ye-Garland Chrysanthemum yi-Apigenin, i-Curcumin, i-Lupeol, i-Daidzein, i-Phloretin. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Epithelial ukuya kwi-Mesenchymal Transition kunye nokulungiswa kwe-DNA kunye nabanye. I-Garland Chrysanthemum ayikhuthazwa xa umngcipheko we-Esophageal Adenocarcinoma xa umngcipheko wezofuzo uhambelana ne-FAT3 kuba yonyusa iindlela zokutyikitya kuyo.

IBHUTTERBURE EYISINXIBA YOMFUNO IYAKUGQIBISWA PHEZU KWEGARLAND IKHRYSANTHEMUM NGEFAT3 GENETIC RISK YOMHLAZA.

Khetha Fruit NANCE okanye EMNYAMA ELDERBERRY?

I-Fruit Nance iqulethe izithako ezininzi ezisebenzayo okanye i-bioactives efana ne-Apigenin, i-Curcumin, i-Lupeol, i-Daidzein, i-Phloretin. Ezi zithako ezisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Cell Cycle, i-Epithelial ukuya kwi-Mesenchymal Transition, i-Growth Factor Signaling kunye ne-P53 Signaling kunye nabanye. I-Nance icetyiswa kumngcipheko we-Esophageal Adenocarcinoma xa umngcipheko wemfuzo ohambelana ne-FAT3. Oku kungenxa yokuba i-Nance yonyusa ezo ndlela zebhayoloji ezichasene nabaqhubi bayo.

Ezinye zezinto ezisebenzayo okanye i-bioactives kwiziqhamo ze-Black Elderberry yi-Apigenin, i-Curcumin, i-Lupeol, i-Daidzein, i-Phloretin. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Epithelial ukuya kwi-Mesenchymal Transition kunye nokulungiswa kwe-DNA kunye nabanye. I-Black Elderberry ayikhuthazwa xa umngcipheko we-Esophageal Adenocarcinoma xa umngcipheko wemfuzo uhambelana ne-FAT3 kuba yonyusa iindlela zokutyikitya.

ISIQHAMO NANCE KUCEBISWA PHEZULU EMNYAMA ELDERBERRY FOR FAT3 genetic RISK OF CANCER.

Khetha Nut COMMON HAZELNUT okanye EUROPEAN CHESTNUT?

I-Hazelnut eqhelekileyo iqulethe izithako ezininzi ezisebenzayo okanye i-bioactives efana ne-Curcumin, i-Lupeol, i-Daidzein, i-Phloretin, i-Lycopene. Ezi zithako ezisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Cell Cycle, i-Epithelial ukuya kwi-Mesenchymal Transition, i-Growth Factor Signaling kunye ne-P53 Signaling kunye nabanye. I-Hazelnut eqhelekileyo iyacetyiswa kumngcipheko we-Esophageal Adenocarcinoma xa umngcipheko wemfuzo ohambelana ne-FAT3. Oku kungenxa yokuba iHazelnut eqhelekileyo yonyusa ezo pathways biochemical ezichasa utyikityo lwabaqhubi bayo.

Ezinye zezinto ezisebenzayo okanye i-bioactives kwi-Chestnut yaseYurophu yi-Apigenin, i-Curcumin, i-Lupeol, i-Ellagic Acid, i-Daidzein. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Epithelial ukuya kwi-Mesenchymal Transition kunye nabanye. I-Chestnut yaseYurophu ayikhuthazwa xa umngcipheko we-Esophageal Adenocarcinoma xa umngcipheko wemfuzo uhambelana ne-FAT3 kuba yonyusa iindlela zokutyikitya.

IHAZELNUT EQHELEKILEYO IYAKUNIKEZWA NGAPHEZU KWE-EUROPEY CHESTNUT FOR FAT3 genetic RISK OF CANCER.

Ukuququmbela

Ukutya kunye nezongezo ezikhethiweyo zizigqibo ezibalulekileyo zomhlaza ezifana ne-Esophageal Adenocarcinoma. Izigulana ze-Esophageal Adenocarcinoma kunye nabantu abasengozini yemfuza bahlala benombuzo: "Kukuphi ukutya kunye nezongezo zesondlo ezicetyiswayo kum kwaye ezingekho?" Kukho inkolelo eqhelekileyo eyingcamango ephosakeleyo yokuba konke ukutya okusekelwe kwizityalo kunokuba luncedo okanye akunjalo kodwa akuyi kuba yingozi. Ukutya okuthile kunye nezongezelelo zinokuphazamisana nonyango lomhlaza okanye zikhuthaze abaqhubi beendlela zeemolekyuli zomhlaza.

Kukho iintlobo ezahlukeneyo zezalathisi zomhlaza ezifana ne-Esophageal Adenocarcinoma, nganye ine-tumor genetics eyahlukeneyo kunye nokwahluka kwe-genomic kumntu ngamnye. Ngaphaya koko, lonke unyango lomhlaza kunye nechemotherapy linendlela eyodwa yokusebenza. Ukutya ngakunye okufana nesipinatshi saseNew Zealand kuqulethe izinto ezahlukeneyo zebhayoloji kwimiyinge eyahlukeneyo, enempembelelo kwiiseti ezahlukeneyo kunye nezahlukileyo zeendlela zebhayoloji. Inkcazo yesondlo somntu siqu zingcebiso zokutya zomntu ngamnye kwisalathiso somhlaza, unyango, imfuzo, indlela yokuphila kunye nezinye izinto. Izigqibo zokwenziwa kwesondlo kumhlaza zifuna ulwazi lwebhayoloji yomhlaza, isayensi yokutya kunye nokuqonda iindlela ezahlukeneyo zonyango lwechemotherapy. Ekugqibeleni xa kukho utshintsho lonyango okanye i-genomics entsha ichongiwe - isondlo somntu sidinga ukuphononongwa kwakhona.

Isisombululo somntu we-addon wesondlo senza ukuba isigqibo sibe lula kwaye sisuse yonke ingqikelelo ekuphenduleni umbuzo othi, "Kukuphi ukutya endimele ndikukhethe okanye ndingakhethi kwi-Esophageal Adenocarcinoma?". Iqela le-addon multi-disciplinary libandakanya oogqirha bomhlaza, izazinzulu zeklinikhi, iinjineli zesoftware kunye nososayensi bedatha.

Ucaphulo

• Tmb Mskcc 2018
• Uhlalutyo lwe-pan-cancer lwe-genomes epheleleyo.
• I-L-Ascorbic Acid Inqanda Ukukhula koMhlaza Webele ngokuNxibisa i-IRE/JNK/CHOP-Enxulumene ne-Endoplasmic Reticulum Stress-Mediated p62/SQSTM1 Ukuqokelela kwi-Nucleus.
• I-β-Sitosterol kunye neGemcitabine Exhibit Synergistic Anti-pancreatic Cancer Activity ngokuModulating i-Apoptosis kunye ne-Inhibiting Epithelial-Mesenchymal Transition ngo-Deactivating Akt / GSK-3β Signaling.
• I-Anti-Metastatic Effects ye-Lupeol nge-Inhibition ye-MAPK / ERK Pathway kwi-Lung Cancer.